Ganciclovir concentrations in the cerebral extracellular space after valganciclovir treatment; a case study

Nearly all glioblastomas (GBMs), brain tumours with very poor prognosis, are infected with human cytomegalovirus (CMV). The anti-CMV drug valganciclovir (VGCV) has shown promise as a treatment option for patients with GBM, but its penetration into the central nervous system (CNS) is unknown. Here we...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:BMJ Case Rep
Egile Nagusiak: Peredo, Inti, Helldén, Anders, Wolmer-Solberg, Nina, Pohanka, Anton, Stragliotto, Giuseppe, Rahbar, Afsar, Ståhle, Lars, Bellander, Bo-Michael, Söderberg-Nauclér, Cecilia
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: BMJ Publishing Group 2015
Gaiak:
Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC4680241/
https://ncbi.nlm.nih.gov/pubmed/26670887
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2014-207694
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak